Nervecentre’s EPMA goes live at Nottingham University Hospitals

Nottingham University Hospitals (NUH) has deployed Nervecentre’s Electronic Prescribing and Medicines Administration (EPMA) solution to improve safety, advance its digital maturity and provide real-time insight into prescribing activities.

City Hospital (City) and Queens Medical Center (QMC) were transferred from paper drug charts to nervecentres over two weekends, with City being the first on 20 May and QMC three weeks later on 10 June.

The QMC Go-Live took place on the hottest weekend of the year and just before a three-day junior doctors’ strike. For QMC, medication charts covering 14,100 prescriptions for more than 800 patients in 40 wards were transferred to the NervCenter over two days.

Clinicians and operational teams at Nottingham University Hospitals NHS Trust were already heavy users of Nervecentre for its comprehensive set of functionality, including test results, vital signs, clinical noting, night hospital, sepsis alert, risk assessment, fluid Includes balance, bed management and. Coolie.

Adding medication management and discharge summary helps physicians aggregate all the information they need in one place – their mobile device.

Later this year, NUH will add a full suite of investigative ordering and emergency department functionality to further strengthen its digital footprint.

NerveCenter’s EPMA allows users to prescribe and administer medications using mobile devices, utilizes closed-loop barcode scanning of patient wristbands and medications to ensure the safest practice at the patient’s bedside, and supports over 12,000 mobile devices. Takes advantage of NUH’s investment in

This mobile-first approach provides physicians with live information about their patients and their medication and is proven to save time and improve safety and usability.

The new system helps increase confidence with automated decision support that includes the use of BNF and Stockley’s Drug-Drug Interactions, SNOMED and DM+D.

Clinical decision support is based on allergy, height/weight, VTE assessment, vital signs and pathology results that are already present in the NerveCenter.

It supports FHIR compliance, and information is shared with GPs using distributed neurocentre discharge summaries over MESH, as well as with community pharmacies through integrated support for FarmOutcome messaging.

initial response positive

The response to Go-Live has been positive since its inception. Doctors have said that EPMA makes their lives easier and improves safety, and nurses appreciate the ability to have all the information in one place instead of wasting time looking for paper charts.

Mark Simmonds, NUH’s deputy medical director, said: “The e-prescription digital solution allows 24/7 access to a patient’s medication records from anywhere and will revolutionize current paper-based medication management processes.”

Paul Volkerts, CEO of NervCenter Software, said: “We are seeing evidence that progressive deployment of EPR provides a high level of physician buy-in from the outset, without the need for a stabilization period.

“NUH has focused on usability – ensuring their staff have tools that are easy to learn and use, and allow them to spend more time caring for patients – and on clinician adoption and satisfaction. They are reaping the rewards of this through a strong level of